ELIQUIS is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Apixaban.
| Product ID | 71610-662_0da24217-d35f-4f62-bfaf-760d6e19301d |
| NDC | 71610-662 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ELIQUIS |
| Generic Name | Apixaban |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-12-28 |
| Marketing Category | NDA / |
| Application Number | NDA202155 |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Substance Name | APIXABAN |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0003-0893 | ELIQUIS | apixaban |
| 0003-0894 | ELIQUIS | apixaban |
| 0003-3764 | ELIQUIS | apixaban |
| 50090-1436 | ELIQUIS | apixaban |
| 50090-1437 | ELIQUIS | apixaban |
| 55154-0612 | ELIQUIS | apixaban |
| 70518-1861 | ELIQUIS | ELIQUIS |
| 55154-0613 | ELIQUIS | ELIQUIS |
| 63629-7747 | ELIQUIS | ELIQUIS |
| 67296-1673 | ELIQUIS | ELIQUIS |
| 14445-149 | apixaban | apixaban |
| 14445-150 | apixaban | apixaban |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ELIQUIS 85544142 4451882 Live/Registered |
Bristol-Myers Squibb Company 2012-02-16 |
![]() ELIQUIS 78775228 not registered Dead/Abandoned |
Pfizer Inc. 2005-12-16 |
![]() ELIQUIS 77933261 not registered Dead/Abandoned |
Pfizer Inc. 2010-02-11 |
![]() ELIQUIS 77933259 not registered Dead/Abandoned |
BRISTOL-MYERS SQUIBB COMPANY 2010-02-11 |
![]() ELIQUIS 77933257 not registered Dead/Abandoned |
Pfizer Inc. 2010-02-11 |
![]() ELIQUIS 77622324 3674414 Live/Registered |
BRISTOL-MYERS SQUIBB COMPANY 2008-11-26 |
![]() ELIQUIS 76388645 3066277 Dead/Cancelled |
BRISTOL-MYERS SQUIBB COMPANY 2002-02-26 |